Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Lyerly

Showing results (41-50 of 59) with videos related to

Pageof 6
Sort By:
Prenatal Diagnosis|February 8, 2022
Parental motivations for and adaptation to trio-exome sequencing in a prospective prenatal testing cohort: Beyond the diagnosisAsha N Talati, Kelly L Gilmore, Emily E Hardisty, et al.
Prenatal Diagnosis|January 23, 2023
Diagnostic yield and psychological outcomes among women pursuing trio-exome sequencing: Do women with recurrent anomalous fetal phenotypes experience more negative psychological outcomes?Asha N Talati, Kelly L Gilmore, Emily E Hardisty, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|November 20, 2020
Impact of prenatal exome sequencing for fetal genetic diagnosis on maternal psychological outcomes and decisional conflict in a prospective cohortAsha N Talati, Kelly L Gilmore, Emily E Hardisty, et al.
Women'S Health Reports (New Rochelle, N.Y.)|May 13, 2022
Emotional Experiences of Pregnant and Postpartum People with Confirmed or Suspected COVID-19 Infection During the Initial Surge of the PandemicNatalie C Spach, Elana F Jaffe, Kristen A Sullivan, et al.
Regulatory Peptides|July 4, 1998
Pharmacological characterization and selectivity of the NPY antagonist GR231118 (1229U91) for different NPY receptorsJ E Matthews, M Jansen, D Lyerly, et al.
Vaccine|January 15, 2021
The need for inclusion of pregnant women in COVID-19 vaccine trialsRichard H Beigi, Carleigh Krubiner, Denise J Jamieson, et al.
Vaccine|July 6, 2013
Expression, purification, and evaluation of recombinant LecA as a candidate for an amebic colitis vaccineL Barroso, M Abhyankar, Z Noor, et al.
Science (New York, N.Y.)|June 23, 2018
Response-Evaluating human trials: FDA's roleS K Shah, J Kimmelman, A D Lyerly, et al.
Science (New York, N.Y.)|April 14, 2018
Bystander risk, social value, and ethics of human researchS K Shah, J Kimmelman, A D Lyerly, et al.
The Journal of Hospital Infection|August 28, 2009
Elevated levels of intestinal inflammation in Clostridium difficile infection associated with fluoroquinolone-resistant C. difficileS W Pawlowski, L Archbald-Pannone, R J Carman, et al.
Pageof 6

Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
Prenatal Diagnosis|February 8, 2022
Parental motivations for and adaptation to trio-exome sequencing in a prospective prenatal testing cohort: Beyond the diagnosisAsha N Talati, Kelly L Gilmore, Emily E Hardisty, et al.
Prenatal Diagnosis|January 23, 2023
Diagnostic yield and psychological outcomes among women pursuing trio-exome sequencing: Do women with recurrent anomalous fetal phenotypes experience more negative psychological outcomes?Asha N Talati, Kelly L Gilmore, Emily E Hardisty, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|November 20, 2020
Impact of prenatal exome sequencing for fetal genetic diagnosis on maternal psychological outcomes and decisional conflict in a prospective cohortAsha N Talati, Kelly L Gilmore, Emily E Hardisty, et al.
Women'S Health Reports (New Rochelle, N.Y.)|May 13, 2022
Emotional Experiences of Pregnant and Postpartum People with Confirmed or Suspected COVID-19 Infection During the Initial Surge of the PandemicNatalie C Spach, Elana F Jaffe, Kristen A Sullivan, et al.
Regulatory Peptides|July 4, 1998
Pharmacological characterization and selectivity of the NPY antagonist GR231118 (1229U91) for different NPY receptorsJ E Matthews, M Jansen, D Lyerly, et al.
Vaccine|January 15, 2021
The need for inclusion of pregnant women in COVID-19 vaccine trialsRichard H Beigi, Carleigh Krubiner, Denise J Jamieson, et al.
Vaccine|July 6, 2013
Expression, purification, and evaluation of recombinant LecA as a candidate for an amebic colitis vaccineL Barroso, M Abhyankar, Z Noor, et al.
Science (New York, N.Y.)|June 23, 2018
Response-Evaluating human trials: FDA's roleS K Shah, J Kimmelman, A D Lyerly, et al.
Science (New York, N.Y.)|April 14, 2018
Bystander risk, social value, and ethics of human researchS K Shah, J Kimmelman, A D Lyerly, et al.
The Journal of Hospital Infection|August 28, 2009
Elevated levels of intestinal inflammation in Clostridium difficile infection associated with fluoroquinolone-resistant C. difficileS W Pawlowski, L Archbald-Pannone, R J Carman, et al.
Pageof 6